Case Report
Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations
Table 1
Clinical characteristics of 4 patients with congenital nephrogenic diabetes insipidus and AVPR2 mutations.
| | Case 1 | Case 2 | Case 3 | Case 4 |
| Sex | Male | Male | Male | Female | AVPR2 mutation | c.299_300insA; p.K100KfsX91 | c.316C > T; p.R106C | c.296G > A; p.W99X | c.296G > A; p.W99X | Age | 3 mo | 19 mo | 4 y | 4 y | Symptoms | Polydipsia, polyuria, poor body weight gain, vomiting, fever | Polydipsia, polyuria, poor body weight gain, low-grade fever | Polydipsia, polyuria | Polydipsia, polyuria | Laboratory data | | | | | Serum Na (mEq/L) | 162 | 139 | 138 | 141 | ADH (pmol/L) | 29.4 | 12.7 | 53.1 | 6.2 | Plasma osmolality (mOsm/L) | 325 | 280 | 278 | 283 | Urine osmolality (mOsm/L) | 183 | 74.0 | 51.0 | 175 | Urologic complications | Mild hydronephrosis (right kidney) | Calcification (right kidney), mild hydronephrosis (left kidney) | None | None | Current treatment | HCTZ SP potassium supplement IDM | TCM SP sodium restriction | HCTZ potassium supplement IDM | HCTZ potassium supplement IDM |
|
|
Time of diagnosis; normal range: 0.9–4.6 pmol/L. ADH, plasma antidiuretic hormone; HCTZ, hydrochlorothiazide; SP, spironolactone; TCM, trichlormethiazide; IDM, indomethacin. |